Metropolis Healthcare Limited (METROPOLIS) Financial History

Name: Metropolis Healthcare Limited (METROPOLIS) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Metropolis Healthcare Limited (METROPOLIS) operates in the Diagnostics & Research industry and is headquartered in Mumbai, India with about 4,484 employees. Its market capitalization is roughly ₹124 billion. In the fiscal year ended 2026-03-31, METROPOLIS reported ₹16.5B in revenue and ₹1.9B in net income.

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally.

Interactive charts & full statements →

METROPOLIS Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹16.5B	₹13.3B	₹12.1B	₹11.5B	—
Gross Profit	₹12.9B	₹10.5B	₹9.5B	₹8.8B	—
Operating Income (EBIT)	₹3.0B	₹2.1B	₹2.0B	₹2.1B	—
Net Income	₹1.9B	₹1.4B	₹1.3B	₹1.4B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

METROPOLIS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹4.5B	₹4.2B	₹4.1B	—	₹3.9B	₹3.5B	—
Gross Profit	₹3.6B	₹3.4B	₹3.2B	—	₹3.0B	₹2.7B	—
Operating Income (EBIT)	₹788M	₹694M	₹630M	—	₹589M	₹337M	—
Net Income	₹567M	₹509M	₹414M	—	₹451M	₹291M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

METROPOLIS Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹207M)	—	(₹205M)	(₹410M)	(₹409M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

METROPOLIS Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹21.4B	₹18.7B	₹15.6B	₹15.0B	—
Total Liabilities	₹6.1B	₹5.3B	₹4.6B	₹5.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive METROPOLIS viewer.

Other Companies in Diagnostics & Research

4544 · H.U. Group Holdings, Inc. — JPY 198 billion
VIJAYA · Vijaya Diagnostic Centre Limited — ₹161 billion
SYNGENE · Syngene International Limited — ₹149 billion
4694 · BML, Inc. — JPY 138 billion
2268 · WuXi XDC Cayman Inc. — HK$98 billion
THYROCARE · Thyrocare Technologies Limited — ₹88 billion
2395 · Shin Nippon Biomedical Laboratories, Ltd. — JPY 55 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — HK$39 billion

← METROGLOBL All “M” companies METU →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.